Abstract
Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have